This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shanghai Institute of Biological Products Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Xiaofei Song
Introduction
Xiaofei Song is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on creating innovative solutions for medical challenges.
Latest Patents
Xiaofei Song holds a patent for an anti-HER3 humanized monoclonal antibody. This antibody is designed to bind to the HER3 antigen, demonstrating high affinity and biological activity while maintaining low immunogenicity. Its structural stability makes it a promising candidate for developing drugs aimed at preventing or treating HER3-related diseases.
Career Highlights
Xiaofei Song is affiliated with the Shanghai Institute of Biological Products Co., Ltd. His role at this esteemed institution allows him to engage in cutting-edge research and development in the field of biological products. His expertise in monoclonal antibodies has positioned him as a key figure in the industry.
Collaborations
Xiaofei has collaborated with notable colleagues, including Aidong Qu and Hongyuan Liang. These partnerships enhance the research efforts and contribute to the advancement of innovative therapies.
Conclusion
Xiaofei Song's work in developing the anti-HER3 humanized monoclonal antibody exemplifies his commitment to advancing medical science. His contributions are vital in the ongoing fight against HER3-related diseases, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile